Berkeley, CA · Founded 2012 · Privately Held (backing)
Developer of biotechnology therapies intended to address inflammatory and degenerative diseases. Aeovian Pharmaceuticals is based in Berkeley, CA and was founded in 2012. It was valued at $172 million at its later-stage round in Dec 2025, the last priced event on record. It has raised $143 million across 3 recorded rounds; the latest was a $55 million later-stage round in Nov 2025.
PMV mark · valuation
$172.0M
Oct 2026
Priced at
its later-stage round
Dec 2025
Total raised
$143.2M
Last round
Later Stage VC
Nov 2025
Cap table — not yet on record
Aeovian Pharmaceuticals's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Aeovian Pharmaceuticals with a free account
·The complete investor list: 22 names
·Watch Aeovian Pharmaceuticals: the Monday email on marks, rounds and moves
Where does Aeovian Pharmaceuticals's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Aeovian Pharmaceuticals's 3 recorded funding rounds.
